Organigram Stock Analysis

OGI -  USA Stock  

USD 3.08  0.04  1.32%

The current Organigram Hlds price drop may encourage stockholders to take a closer look at the company as it is trading at a share price of 3.08 on 3,269,420 in trading volume. The company directors and management were unable to exploit market volatilities in May. However, diversifying your overall positions with Organigram Hlds can protect your principal portfolio during market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 5.06. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Organigram Hlds partners.
Please check Your Equity Center.

Search Stock Analysis 

 
Refresh
The Organigram Hlds stock analysis report makes it easy to digest most publicly released information about Organigram Hlds and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Organigram stock analysis module also helps to analyze the Organigram Hlds price relationship with some important fundamental indicators such as market cap and management efficiency.

Organigram Stock Analysis Notes

About 20.0% of the company outstanding shares are owned by corporate insiders. The book value of Organigram Hlds was now reported as 1.14. The company recorded a loss per share of 0.93. Organigram Hlds had not issued any dividends in recent years. The entity had a split on the 28th of January 2015. Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada. Organigram Hlds operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 619 people. To find out more about Organigram Hlds contact the company at 506 801 8986 or learn more at http://www.organigram.ca.

Organigram Hlds Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Organigram Hlds' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Organigram Hlds or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Organigram Hlds generates negative expected return over the last 90 days
Organigram Hlds has high historical volatility and very poor performance
The company reported the last year's revenue of 72.39 M. Reported Net Loss for the year was (229.19 M) with loss before taxes, overhead, and interest of (50.4 M).
Organigram Hlds has about 71.12 M in cash with (17.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.24.
Roughly 20.0% of the company outstanding shares are owned by corporate insiders

Organigram Hlds Upcoming and Recent Events

Earnings reports are used by Organigram Hlds to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Organigram Hlds previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report13th of April 2021
Next Earnings Report20th of July 2021
Next Fiscal Quarter End28th of February 2021
Next Fiscal Year End29th of November 2021
Last Quarter Report30th of November 2020
Last Earning Announcement29th of February 2020

Organigram Largest EPS Surprises

Earnings surprises can significantly impact Organigram Hlds' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2017-12-18
2017-11-30-0.012-0.0148-0.002823 
2017-07-28
2017-05-31-0.007-0.0185-0.0115164 
2018-04-24
2018-02-28-0.0080.00620.0142177 
View All Earnings Estimates

Organigram Hlds SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Organigram Hlds prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Organigram Hlds investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Organigram Hlds specific information freely available to individual and institutional investors to make a timely investment decision.

Organigram Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Organigram Hlds is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Organigram Hlds backward and forwards among themselves. Organigram Hlds' institutional investor refers to the entity that pools money to purchase Organigram Hlds' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Etf Managers Group LlcCommon Shares16.6 M57.8 M
Mirae Asset Global Investments Co LtdCommon SharesM14 M
Millennium Management LlcCommon Shares3.4 M11.7 M
Susquehanna International Group LlpCall Options1.9 M6.5 M
Penserra Capital Management LlcCommon Shares1.2 M4.3 M
Jane Street Group LlcPut Options1.1 MM
Td Asset Management IncCommon Shares798.7 K2.8 M
Public Sector Pension Investment BoardCommon Shares628 K2.2 M
Swiss National BankCommon Shares533 K1.8 M
Note, although Organigram Hlds' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Organigram Market Capitalization

The company currently falls under 'Small-Cap' category with total capitalization of 947.17 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Organigram Hlds's market, we take the total number of its shares issued and multiply it by Organigram Hlds's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has Return on Asset of (21.4) % which means that on every $100 spent on asset, it lost $21.4. This is way below average. In the same way, it shows return on shareholders equity (ROE) of (71.03) %, meaning that it generated no profit with money invested by stockholders. Organigram Hlds management efficiency ratios could be used to measure how well organigram hlds manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 17th of June 2021, Organigram Hlds holds the risk adjusted performance of (0.042959), and Coefficient Of Variation of (1,209). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Organigram Hlds, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Organigram Hlds, which can be compared to its competitors. Please check Organigram Hlds information ratio, as well as the relationship between the value at risk and expected short fall to decide if Organigram Hlds is priced some-what accurately, providing market reflects its current price of 3.08 per share. Given that Organigram Hlds has jensen alpha of (0.44), we recommend you to check out Organigram Hlds's recent market performance to make sure the company can sustain itself at a future point.

Organigram Hlds Price Movement Analysis

The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Exponential Moving Average is calculated by weighting recent values of Organigram Hlds more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

Organigram Hlds Predictive Daily Indicators

Organigram Hlds intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Organigram Hlds stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Organigram Hlds Forecast Models

Organigram Hlds time-series forecasting models is one of many Organigram Hlds' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Organigram Hlds' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Organigram Hlds Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Organigram Hlds stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Organigram shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Organigram Hlds. By using and applying Organigram Stock analysis, traders can create a robust methodology for identifying Organigram entry and exit points for their positions.
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada. Organigram Hlds operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 619 people.

Current Organigram Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Organigram analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Organigram analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
2.04Hold11Odds
Organigram Hlds current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Organigram analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Organigram stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Organigram Hlds, talking to its executives and customers, or listening to Organigram conference calls.
Organigram Analyst Advice Details

Organigram Stock Analysis Indicators

Organigram Hlds stock analysis indicators help investors evaluate how Organigram Hlds stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Organigram Hlds shares will generate the highest return on investment. By understating and applying Organigram Hlds stock analysis, traders can identify Organigram Hlds position entry and exit signals to maximize returns.
Quick Ratio4.11
Fifty Two Week Low1.0100
Revenue Growth-36.90%
Shares Short Prior Month14.2M
Average Daily Volume Last 10 Day8.07M
Average Daily Volume In Three Month9.6M
Shares Percent Shares Out4.63%
Gross Margins-147.45%
Float Shares239.56M
Fifty Two Week High6.4500
Enterprise Value To Ebitda-5.65
Fifty Day Average2.7993
Two Hundred Day Average2.5855
Enterprise Value To Revenue10.44
Please check Your Equity Center. Note that the Organigram Hlds information on this page should be used as a complementary analysis to other Organigram Hlds' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Search module to search for activelly-traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Organigram Hlds Stock analysis

When running Organigram Hlds stock analysis, check to measure Organigram Hlds' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organigram Hlds is operating at the current time. Most of Organigram Hlds' stock examination focuses on studying past and present price action to predict the probability of Organigram Hlds' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Organigram Hlds' price. Additionally, you may evaluate how the addition of Organigram Hlds to your portfolios can decrease your overall portfolio volatility.
ETF Directory
Find actively-traded Exchange Traded Funds (ETF) from around the world
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
The market value of Organigram Hlds is measured differently than its book value, which is the value of Organigram that is recorded on the company's balance sheet. Investors also form their own opinion of Organigram Hlds stock's value that differs from its market value or its book value, called intrinsic value, which is Organigram Hlds' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organigram Hlds' market value can be influenced by many factors that don't directly affect Organigram Hlds underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organigram Hlds' stock value and its price as these two are different measures arrived at by different means. Investors typically determine Organigram Hlds value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organigram Hlds' stock price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.